https://www.tga.gov.au/scheduling-decision-final/notice-final-decisions-amend-or-not-amend-current-poisons-standard-relation-psilocybin-and-mdma
The decision is in, the TGA won’t (at this stage) down schedule these substances.
I feel the reasoning provided is sound, and the TGA has essentially indicated they are awaiting further phase 3 results.
note - this doesn’t at all impact the ability of Emyria to keep researching these drugs! Nor does it impact their cannabinoid work (promising bioavailability data out today in a separate announcement!).
if there’s a dip, I’ll be buying it.
https://www.tga.gov.au/scheduling-decision-final/notice-final-dec...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.3¢ |
Change
-0.002(5.71%) |
Mkt cap ! $20.17M | |||
| Open | High | Low | Value | Volume |
| 3.4¢ | 3.4¢ | 3.2¢ | $51.43K | 1.552M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 295884 | 3.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.4¢ | 1185025 | 2 |
View Market Depth
| Last trade - 15.59pm 21/07/2025 (20 minute delay) ? |
| EMD (ASX) Chart |